(Q57088808)

English

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

article by Alice Dewdney et al published 10 May 2012 in Journal of Clinical Oncology

Statements

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C) (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Jaume Capdevila
0 references
Andres Cervantes
0 references
Diana Tait
0 references
David Gonzalez de Castro
0 references
Yu Jo Chua
0 references
10 May 2012
0 references
30
0 references
14
0 references
1620-1627
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit